Compare Stocks: TWST, TXG, DNA, and MTD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DNA Ginkgo Bioworks	$12.95 +14.2%	$8.56	$5.37 ▼ $18.22	$875.42M	1.79	3.41 million shs	4.51 million shs
MTD Mettler-Toledo International	$1,551.26 +1.4%	$1,424.82	$1,023.05 ▼ $1,585.72	$31.06B	1.19	222,025 shs	180,642 shs
TWST Twist Bioscience	$159.78 +5.1%	$144.32	$23.30 ▼ $219.71	$10.02B	2.19	3.12 million shs	3.54 million shs
TXG 10x Genomics	$80.65 +4.4%	$68.66	$11.16 ▼ $102.81	$10.51B	1.99	3.99 million shs	3.68 million shs

10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DNA Ginkgo Bioworks	0.00%	+4.95%	+91.14%	+42.31%	-19.52%
MTD Mettler-Toledo International	0.00%	+4.26%	+21.12%	+19.65%	+16.77%
TWST Twist Bioscience	0.00%	-15.31%	+25.96%	+76.28%	+387.28%
TXG 10x Genomics	0.00%	-13.74%	+21.50%	+88.74%	+568.19%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DNA Ginkgo Bioworks	$12.95 +14.2%	$8.56	$5.37 ▼ $18.22	$875.42M	1.79	3.41 million shs	4.51 million shs
MTD Mettler-Toledo International	$1,551.26 +1.4%	$1,424.82	$1,023.05 ▼ $1,585.72	$31.06B	1.19	222,025 shs	180,642 shs
TWST Twist Bioscience	$159.78 +5.1%	$144.32	$23.30 ▼ $219.71	$10.02B	2.19	3.12 million shs	3.54 million shs
TXG 10x Genomics	$80.65 +4.4%	$68.66	$11.16 ▼ $102.81	$10.51B	1.99	3.99 million shs	3.68 million shs

10 Best Stocks to Own in Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DNA Ginkgo Bioworks	0.00%	+4.95%	+91.14%	+42.31%	-19.52%
MTD Mettler-Toledo International	0.00%	+4.26%	+21.12%	+19.65%	+16.77%
TWST Twist Bioscience	0.00%	-15.31%	+25.96%	+76.28%	+387.28%
TXG 10x Genomics	0.00%	-13.74%	+21.50%	+88.74%	+568.19%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DNA Ginkgo Bioworks	1.50	Reduce	$6.33	-51.09% Downside
MTD Mettler-Toledo International	2.27	Hold	$1,459.54	-5.91% Downside
TWST Twist Bioscience	2.46	Hold	$128.17	-19.79% Downside
TXG 10x Genomics	2.28	Hold	$58.60	-27.34% Downside

Current Analyst Ratings Breakdown

Latest TWST, TXG, DNA, and MTD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/8/2026	TWST Twist Bioscience	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Hold	$150.00
10/7/2026	TWST Twist Bioscience	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$112.00 ➝ $215.00
10/7/2026	TXG 10x Genomics	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$52.00 ➝ $110.00
10/7/2026	MTD Mettler-Toledo International	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$1,575.00 ➝ $1,700.00
10/1/2026	TWST Twist Bioscience	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$107.00 ➝ $212.00
9/29/2026	TXG 10x Genomics	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Market Perform	$40.00 ➝ $90.00
9/29/2026	TWST Twist Bioscience	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$160.00 ➝ $190.00
9/28/2026	TXG 10x Genomics	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$47.00 ➝ $80.00
9/28/2026	TXG 10x Genomics	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$110.00
9/21/2026	TWST Twist Bioscience	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
9/21/2026	TXG 10x Genomics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)

(Data available from 10/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DNA Ginkgo Bioworks	$170.15M	5.13	N/A	N/A	$8.74 per share	1.48
MTD Mettler-Toledo International	$4.03B	7.72	$49.67 per share	31.23	($1.16) per share	-1,337.29
TWST Twist Bioscience	$376.57M	26.61	N/A	N/A	$7.84 per share	20.38
TXG 10x Genomics	$642.82M	16.35	N/A	N/A	$6.24 per share	12.92

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DNA Ginkgo Bioworks	-$312.76M	-$5.01	N/A	N/A	N/A	-259.96%	-60.27%	-26.88%	11/5/2026 (Estimated)
MTD Mettler-Toledo International	$869.19M	$44.43	34.91	29.68	3.11	21.91%	-1,212.14%	25.11%	11/5/2026 (Estimated)
TWST Twist Bioscience	-$77.67M	-$2.22	N/A	N/A	N/A	-31.66%	-28.64%	-19.94%	11/13/2026 (Estimated)
TXG 10x Genomics	-$43.54M	-$0.59	N/A	N/A	N/A	-12.18%	-9.33%	-7.30%	11/5/2026 (Estimated)

Latest TWST, TXG, DNA, and MTD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2026	Q3 2026	DNA Ginkgo Bioworks	-$0.58	N/A	N/A	N/A	$21.57 million	N/A
11/5/2026	Q3 2026	MTD Mettler-Toledo International	$12.12	N/A	N/A	N/A	$1.07 billion	N/A
11/5/2026	Q3 2026	TXG 10x Genomics	-$0.2625	N/A	N/A	N/A	$147.92 million	N/A
8/6/2026	Q2 2026	TXG 10x Genomics	-$0.2431	-$0.14	+$0.1031	-$0.14	$146.67 million	$151.04 million
8/5/2026	Q2 2026	DNA Ginkgo Bioworks	-$0.8950	-$0.75	+$0.1450	-$0.75	$24.05 million	$20.16 million
8/3/2026	Q3 2026	TWST Twist Bioscience	-$0.5063	-$0.56	-$0.0538	-$0.56	$114.55 million	$118.38 million
7/31/2026	Q2 2026	MTD Mettler-Toledo International	$10.78	$11.46	+$0.68	$11.55	$1.03 billion	$1.03 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DNA Ginkgo Bioworks	N/A	N/A	N/A	N/A	N/A
MTD Mettler-Toledo International	N/A	N/A	N/A	N/A	N/A
TWST Twist Bioscience	N/A	N/A	N/A	N/A	N/A
TXG 10x Genomics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DNA Ginkgo Bioworks	N/A	4.57	4.57
MTD Mettler-Toledo International	159.45	1.12	0.78
TWST Twist Bioscience	0.03	2.67	2.38
TXG 10x Genomics	N/A	5.69	5.25

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DNA Ginkgo Bioworks	78.63%
MTD Mettler-Toledo International	95.07%
TWST Twist Bioscience	N/A
TXG 10x Genomics	84.68%

Insider Ownership

Company	Insider Ownership
DNA Ginkgo Bioworks	12.69%
MTD Mettler-Toledo International	0.71%
TWST Twist Bioscience	3.08%
TXG 10x Genomics	8.84%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DNA Ginkgo Bioworks	485	67.34 million	58.80 million	Optionable
MTD Mettler-Toledo International	18,100	20.04 million	19.90 million	Optionable
TWST Twist Bioscience	979	62.71 million	60.78 million	Optionable
TXG 10x Genomics	1,178	130.29 million	118.77 million	Optionable

TWST, TXG, DNA, and MTD Headlines

Recent News About These Companies

10x Genomics $TXG Holdings Decreased by Mirador Capital Partners LP

October 10 at 4:15 AM | marketbeat.com

Why are 10x Genomics (TXG) shares soaring today

October 9 at 8:37 PM | msn.com

10x Genomics (NASDAQ:TXG) Shares Climb 9.2% - Still a Buy?

October 9 at 11:39 AM | marketbeat.com

Is 10x Genomics (TXG) Using Its Fred Hutch Oncology Alliance To Redefine Its Clinical Moat?

October 9 at 9:10 AM | finance.yahoo.com

10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research

October 8 at 11:26 AM | zacks.com

10x Genomics Enters Research Collaboration With Fred Hutchinson Cancer Center

October 8 at 9:45 AM | finance.yahoo.com

10x Genomics Announces New Collaboration to Advance Single Cell and Spatial Applications Across Solid Tumors and Blood Cancers

October 7, 2026 | prnewswire.com

10x Genomics (NASDAQ:TXG) Stock Falls 6.2% - Here's Why

October 6, 2026 | marketbeat.com

10x Genomics Slides as Rally Cools After Recent Product-Launch Surge

October 6, 2026 | quiverquant.comQ

10x Genomics (TXG) Starts Atera Shipments And Sentira, Is The Upside Already Priced In?

October 5, 2026 | finance.yahoo.com

10x Genomics (NASDAQ:TXG) Sets New 52-Week High - Here's What Happened

October 5, 2026 | americanbankingnews.com

10x Genomics (NASDAQ:TXG) Reaches New 52-Week High - What's Next?

October 5, 2026 | marketbeat.com

10x Genomics consensus price target raised 12.04% to MX$958.28

October 3, 2026 | msn.com

10x Genomics consensus price target increased by 13.66% to $60.62

October 2, 2026 | msn.com

10x Genomics $TXG Holdings Trimmed by Versant Capital Management Inc

October 2, 2026 | marketbeat.com

Leerink Partners Sticks to Its Hold Rating for 10x Genomics (TXG)

October 1, 2026 | theglobeandmail.com

10x Genomics Begins Atera Shipments as Spatial Biology Demand Rises

September 30, 2026 | zacks.com

Atera’s Rapid Commercial Traction and Expanding Product Roadmap Underpin Buy Rating on 10x Genomics

September 29, 2026 | tipranks.com

10x Genomics Announces Sentira, a New Computational Platform to Turn Complex Biological Data Into Experimental Conclusions

September 29, 2026 | prnewswire.com

10x Genomics Begins Global Shipments of Atera, Putting Unprecedented Spatial Biology Capabilities in Researchers' Hands

September 29, 2026 | prnewswire.com

10x Genomics (NASDAQ:TXG) Sets New 1-Year High - What's Next?

September 28, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TWST, TXG, DNA, and MTD Company Descriptions

Ginkgo Bioworks NYSE:DNA

$12.95 +1.61 (+14.20%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$13.02 +0.07 (+0.54%)

As of 10/9/2026 07:59 PM Eastern

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Mettler-Toledo International NYSE:MTD

$1,551.26 +21.80 (+1.43%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$1,549.92 -1.34 (-0.09%)

As of 10/9/2026 08:00 PM Eastern

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.

Twist Bioscience NASDAQ:TWST

$159.78 +7.73 (+5.08%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$162.14 +2.36 (+1.48%)

As of 10/9/2026 07:58 PM Eastern

Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels, primarily used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, the company provides synthetic SARS-CoV-2 RNA reference sequences as positive controls for the development of both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries used for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

10x Genomics NASDAQ:TXG

$80.65 +3.37 (+4.36%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$80.99 +0.34 (+0.42%)

As of 10/9/2026 07:57 PM Eastern

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TWST, TXG, DNA, and MTD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TWST, TXG, DNA, and MTD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TWST, TXG, DNA, and MTD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TWST, TXG, DNA, and MTD Company Descriptions

Ginkgo Bioworks NYSE:DNA

Mettler-Toledo International NYSE:MTD

Twist Bioscience NASDAQ:TWST

10x Genomics NASDAQ:TXG

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TWST, TXG, DNA, and MTD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TWST, TXG, DNA, and MTD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TWST, TXG, DNA, and MTD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TWST, TXG, DNA, and MTD Company Descriptions

Ginkgo Bioworks NYSE:DNA

Mettler-Toledo International NYSE:MTD

Twist Bioscience NASDAQ:TWST

10x Genomics NASDAQ:TXG

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools